XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,476,000 | -44.8% | 602,634 | -8.2% | 0.00% | – |
| Q2 2021 | $2,673,000 | +26.5% | 656,742 | +40.1% | 0.00% | – |
| Q1 2021 | $2,113,000 | -26.7% | 468,662 | -20.0% | 0.00% | – |
| Q4 2020 | $2,882,000 | +144.7% | 585,797 | +194.8% | 0.00% | – |
| Q3 2020 | $1,178,000 | +392.9% | 198,706 | +121.1% | 0.00% | – |
| Q2 2020 | $239,000 | +443.2% | 89,888 | +299.5% | 0.00% | – |
| Q1 2020 | $44,000 | -43.6% | 22,500 | +104.5% | 0.00% | – |
| Q4 2019 | $78,000 | -74.1% | 11,000 | -63.3% | 0.00% | – |
| Q1 2019 | $301,000 | +40.7% | 29,941 | +165.2% | 0.00% | – |
| Q2 2018 | $214,000 | – | 11,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |